Thanh Cong Nguyen

Thanh Cong Nguyen

Auto-generated profile, based on publicly available information

Thanh Cong Nguyen

Cardiovascular Center, University Medical Center Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
VVVu Hoang Vu
Vu Hoang Vu
TNThanh Cong Nguyen
Thanh Cong Nguyen
QPQuang Dang Duy Pham
Quang Dang Duy Pham
DPDan Ngoc Pham
Dan Ngoc Pham
LLLe Bao Le
Le Bao Le
KLKhoi Minh Le
Khoi Minh Le
Background: Myocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed to assess the impact of myocardial injury on both acute-phase and long-term prognosis in COVID-19 patients.Methods: A retrospective, observational study was conducted on all patients who received treatment at the Intensive Care Center for COVID-19 patient, University Medical Center Ho Chi Minh City (UCICC), from August 3rd, 2021, to October 28th, 2021.Results: A total of 582 patients were enrolled in the study, of which 55.3% were female. The mean age of participants was 63.3 ± 16.2. Out of these patients, 330 cases (56.8%) showed myocardial injury. Compared to patients without myocardial injury, those with myocardial injury were older and had a higher incidence of chronic diseases including hypertension, ischemic heart disease, atrial fibrillation, heart failure, diabetes mellitus, chronic kidney disease. They also presented with more severe respiratory failure upon admission and showed a more pronounced abnormality in inflammation and kidney function tests. Furthermore, the in-hospital mortality rate was significantly higher in the group with myocardial injury (49.7% vs 14.3%, p < 0.001). After adjusting for age, gender, comorbidities, renal function, and disease severity at admission, myocardial injury emerged as an independent risk factor for in-hospital mortality (OR = 3.758, 95% CI 1.854–7.678, p < 0.001). Among successfully discharged COVID-19 patients, the all-cause mortality rate after a median follow-up of 18.4 months was 7.9%. Patients with myocardial injury had a significantly higher long-term mortality rate compared to those without myocardial injury (14.0% vs. 3.2%, p < 0.001). However, multivariable Cox regression analysis did not find myocardial injury to be a significant predictor of long-term mortality (HR = 2.128, 95% CI 0.792–5.712, p = 0.134).Conclusions: Myocardial injury is a common and serious complication in hospitalized COVID-19 patients, associated with increased in-hospital mortality. However, it does not significantly impact long-term mortality in successfully discharged COVID-19 patients.

Verified
Journal Article
Open access
PDF file
Vu Bao-QuocVu Bao-Quoc
Vu Bao-Quoc
PHPhuong Anh Huynh
Phuong Anh Huynh
Nhu NguyenNhu Nguyen
Nhu Nguyen
NVNiem Vo
Niem Vo
GLGia-Hoang Linh Le
Gia-Hoang Linh Le
DVDiem My Vu
Diem My Vu
Heart failure (HF) is a complex and multifactorial syndrome with high morbidity and mortality rates worldwide. Accumulative evidence suggests that microRNAs (miRNAs) play critical roles in maintaining cardiac homeostasis. The dysregulation of various miRNAs has been reported in different studies on failing human hearts. However, little is known about their circulatory profile. In this study, comprehensive miRNA profiling was performed by next-generation sequencing for plasma samples of 24 HF and 24 age and sex-matched, non-HF patients. A total of 1391 miRNAs were detected, of which 228 miRNAs and 261 miRNAs were commonly expressed in the HF and non-HF groups, respectively. Eight miRNAs (hsa-let-7b-3p, hsa-miR-92b-5p, hsa-miR-145-3p, hsa-miR-206, hsa-miR-664a-5p, hsa-miR-1307-5p, hsa-miR-1908-5p, and hsa-miR-3074-5p) were found to be dysregulated between HF and non-HF patients. The expression of another seven miRNAs (hsa-miR-589-5p, hsa-miR-30b-5p, hsa-miR-654-3p, hsa-miR-1292-5p, hsa-miR-659-5p, hsa-miR-548d-5p, and hsa-miR-7847-3p) was frequently observed in HF patients but not in non-HF cases. Subsequent analyses of target gene prediction and associated pathways revealed the enrichment of pathways related to vascular development, the cell cycle, and transcriptional activity. These data reveal the expression profile and the dysregulation of circulating miRNAs in our patients with HF.

5 February 2025 in JACC: Case Reports
Verified
Journal Article
Open access
VVVu Hoang Vu
Vu Hoang Vu
TNThanh Cong Nguyen
Thanh Cong Nguyen
DNDinh Hoang Nguyen
Dinh Hoang Nguyen
THThang Duc Ho
Thang Duc Ho
BTBinh Quang Truong
Binh Quang Truong
Nose cone entrapment is a rare but serious complication of transcatheter aortic valve replacement (TAVR) that requires prompt recognition and management to prevent adverse outcomes. A 77-year-old man with severe aortic stenosis underwent TAVR with a 29-mm Evolut R valve (Medtronic). The nose cone became lodged at the distal stent frame as a result of infolding, caused by a calcified nodule. Standard maneuvers failed, but the complication was successfully resolved using a snare device deployed through contralateral femoral artery access without damage to the prosthesis. Few similar cases have been reported. This case underscores the importance of recognizing risk factors such as severe calcification, significant annular angulation, and large-diameter valves. It also highlights the snare technique as an appropriate, minimally invasive solution for resolving nose cone entrapment. The snare technique is a reliable approach to manage nose cone entrapment during TAVR.

31 March 2024 in MedPharmRes
Verified
Journal Article
Open access
PDF file
HVHoang Vu Vu
Hoang Vu Vu
TNThanh Cong Nguyen
Thanh Cong Nguyen
BNBinh Thi Hai Nguyen
Binh Thi Hai Nguyen
HTHoa Tran
Hoa Tran
BTBinh Quang Truong
Binh Quang Truong
MedPharmRes is owned by the University of Medicine and Pharmacy at Ho Chi Minh City and published under Open Access arrangement. MedPharmRes publishes quarterly and covers all fields in medicine, public health, epidemiology, and pharmacy, including drug synthesis and delivery and health and medical education research, in an attempt to bridge the gaps between healthcare and clinical specialization. The journal’s publication criteria are based on the accuracy of the research methodology and high ethical standards.

31 March 2024 in MedPharmRes
Verified
Journal Article
Open access
HVHoang Vu Vu
Hoang Vu Vu
TNThanh Cong Nguyen
Thanh Cong Nguyen
BNBinh Thi Hai Nguyen
Binh Thi Hai Nguyen
HTHoa Tran
Hoa Tran
BTBinh Quang Truong
Binh Quang Truong
Takotsubo cardiomyopathy is a condition of transient systolic dysfunction triggered by emotional or physical stress. Nowadays, Takotsubo cardiomyopathy is gaining attention and has been detected more frequently. However, there is no collected data on Vietnamese subjects. This study aims to describe the clinical characteristics of patients diagnosed with Takotsubo cardiomyopathy and determine of rates and independent risk factors for in-hospital mortality. A retrospective andobservational study was conducted at the University Medical Center Ho Chi Minh City, involved 103 patients diagnosed with Takotsubo cardiomyopathy between January 2015 and June 2022. The diagnosis was made based on the revised Mayo Clinic diagnostic criteria. The average age of the study population was 71.2±15.3 years, with females accounting for 64.1% of the patients. The most common comorbidities among the patients were hypertension (57.3%), diabetes mellitus (30.1%), ischemic heart disease (15.5%), and chronic obstructive pulmonary disease (15.5%). Acute heart failure was observed in 30.1% of the patients, while ventricular arrhythmias were present in 17.6% of cases. The majority of triggers were attributed to physical factors, including infection (37.9%), respiratory failure (18.4%), postoperative status (3.9%), and acute neurological disease (2.9%). The in-hospital mortality rate was 17.5%, and the independent risk factors were identified as acute heart failure (OR=20.657, 95%CI 2.306–185.008, p=0.007) and respiratory failure (OR=10.397, 95% CI 1.117–96.795, p=0.040). Takotsubo cardiomyopathy patients have many comorbidities and are often triggered by physical factors. The in-hospital mortality rate is significant, with acute heart failure and respiratory failure identified as independent risk factors.

30 September 2024 in Tạp chí Y học Việt Nam
Verified
Journal Article
Open access
PDF file
HVHoàng Vũ Vũ
Hoàng Vũ Vũ
CNCông Thành Nguyễn
Công Thành Nguyễn
HTHòa Trần
Hòa Trần
QTQuang Bình Trương
Quang Bình Trương
Đặt vấn đề: Khoan cắt mảng xơ vữa là phương pháp hỗ trợ trong can thiệp động mạch vành (ĐMV) qua da cho tổn thương vôi hóa. Tuy nhiên, vẫn còn nhiều tranh cãi về phương pháp thực hiện cũng như hiệu quả và tính an toàn của kỹ thuật này. Mục tiêu nghiên cứu: Khảo sát tình hình thực hiện, đánh giá hiệu quả và tính an toàn của kỹ thuật khoan cắt mảng xơ vữa bằng Rotablator trong can thiệp ĐMV qua da. Đối tượng - phương pháp nghiên cứu: Nghiên cứu quan sát, hồi cứu thực hiện trên 223 trường hợp được thực hiện khoan cắt mảng xơ vữa bằng Rotablator tại bệnh viện Đại học Y Dược TP.HCM từ 01/01/2019 đến 31/10/2023. Kết quả: Tuổi trung bình của dân số nghiên cứu là 69,5±9,6, với 59,6% là nam giới. 78,9% bệnh nhân nhập viện vì hội chứng ĐMV cấp, trong đó 74,9% có bệnh ba nhánh ĐMV, vị trí tổn thương đích phổ biến nhất là động mạch liên thất trước (66,4%). Siêu âm trong lòng mạch được sử dụng ở 93,6% trường hợp. Chiến lược khoan cắt mảng xơ vữa ngay từ đầu được áp dụng ở 67,7% trường hợp. Tỷ lệ thành công trên hình ảnh chụp mạch đạt 96,4%. Các biến chứng liên quan thủ thuật gồm có thủng ĐMV (2,2%), bóc tách ĐMV (2,2%), chậm hoặc mất dòng chảy (4,0%), chèn ép tim cấp (0,9%). Trong thời gian nằm viện, tỷ lệ biến cố tim mạch chính là 8,5%, chủ yếu là nhồi máu cơ tim sau thủ thuật (5,8%). Kết luận: Kỹ thuật khoan cắt mảng xơ vữa bằng Rotablator trong can thiệp ĐMV qua da là phương pháp điều trị an toàn và hiệu quả với tỷ lệ thành công cao